logo
Select company
Select metric
$ 0Non-Current Debt
VS
Market
87
Sector
84
Industry
78
History
33
$ 5.4Close
$ 1.02 - $ 5.63 52-Week Range
Ticker Information

Ticker

ENTO

Company Name

ENTERO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTERO THERAPEUTICS INC - Non-Current Debt Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTO - DebtNC Historical data
DateNon-Current Debt
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 59.02K
9/30/2024$ 80.21K
6/30/2024$ 101.03K
3/31/2024$ 6.53M
12/31/2023$ 146.95K
9/30/2023$ 165.97K
6/30/2023$ 184.66K
3/31/2023$ 196.52K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTERO THERAPEUTICS INC's latest trailing twelve months (TTM) DebtNC stands at $ 0.
  • Over the past 5 years, ENTERO THERAPEUTICS INC's average DebtNC has been $ 420.89K.
  • The median DebtNC for ENTERO THERAPEUTICS INC during this period was $ 90.62K
  • ENTERO THERAPEUTICS INC reached its highest DebtNC over the past 5 years at $ 6.53M.
  • The lowest DebtNC recorded by ENTERO THERAPEUTICS INC in the same timeframe $ 0

Definition of Non-Current Debt

[Balance Sheet] The non-current (long-term) portion of [Debt] includes the formal borrowings that are due after the period of one year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]

ENTO - Non-Current Debt, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 6.53M

Maximum

Mar 31, 2024

$ 420.89K

Average

$ 90.62K

Median

DebtNC Benchmark Analysis

The chart above depicts the distribution of DebtNC for companies in the Total Stock Market. The average DebtNC of the companies is $ 67.73M with a standard deviation of $ 115.49M.
The following table provides additional summary stats:
DebtNC in the Market:
filtered constituents2.41K
min$ 0
max$ 478.7M
average$ 67.73M
median$ 7.94M
std$ 115.49M